Cytophage Technologies Ltd. (TSXV:CYTO)

Canada flag Canada · Delayed Price · Currency is CAD
0.2000
+0.0100 (5.26%)
Apr 25, 2025, 4:00 PM EDT
-39.39%
Market Cap 10.79M
Revenue (ttm) n/a
Net Income (ttm) -7.91M
Shares Out 53.94M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 66,600
Average Volume 23,905
Open 0.1900
Previous Close 0.1900
Day's Range 0.1900 - 0.2100
52-Week Range 0.1250 - 0.5800
Beta 0.31
RSI 70.22
Earnings Date May 1, 2025

About Cytophage Technologies

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Winnipeg, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Steven Theriault
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol CYTO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.